Genentech

Our Promise is our north star for ourselves, patients, and society. It builds upon our history of forging life-altering scientific breakthroughs and reminds us that we are on a bolder quest than ever before - to be courageous changemakers in solving the world’s most complex health challenges and improving the lives of all patients. http://spr.ly/6049V62k7

At this year's #ARVO2024 meeting, we are presenting data that uses proprietary AI models developed by our company. Daniela Ferrara, Principal Medical Director, sheds light on how we are harnessing the power of AI to transform vision research and care. http://spr.ly/6048jpBqn

Our ophthalmology experts, Chris Brittain and Dolly Chang are currently at #ARVO2024 sharing the latest and greatest in our cutting-edge research. This week, they’re connecting with other experts in the field to share insights and build collaborations. Catch up with Chris and Dolly in S5E02 of our #podcast, Two Scientists Walk Into a Bar as they discuss the past, present and future of eye treatments. http://spr.ly/6048jUgdG

As a proud member of the San Mateo County business community, we recognize that quality child care is critical to the economic health of our county, businesses, and our families. And we are committed to collaborating across the county to create tangible solutions that increase access. We recently welcomed a group of leaders to our South San Francisco campus to discuss the importance of childcare in the county. The discussions highlighted the urgent need for action and collaboration and served as a reminder that creating accessible childcare requires a collective effort. By joining forces and leveraging our shared resources, we can design a future where every child has access to quality care. Learn more here: http://spr.ly/6041jl6QZ

Congratulations to Diana C. Lozano, PhD, recipient of the 2024 Genentech Career Development Award for Underrepresented Minority (URM) Emerging Vision Scientists! Dr. Lozano, Assistant Professor at OHSU Casey Eye Institute, will receive a two-year grant to support research and personnel costs for establishing an independent vision research program. Dr. Lozano received recognition at this year’s Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Seattle. We're proud to support talented women like Dr. Lozano in their groundbreaking work.

Christopher Brittain, our VP Global Head of Ophthalmology Product Development, shares insights on our leadership and innovation in #ophthalmology at this year’s #ARVO2024 meeting. With over 18 years of experience spanning medical practice and pharmaceuticals, Chris leads our ophthalmology team in shaping clinical development, driving groundbreaking solutions for vision loss and eye health. Learn more about a few of our clinical developments that are being presented at ARVO 2024 here: http://spr.ly/6045jpBPD

As we wrap up the inaugural National Cancer Prevention and Early Detection Month, we're proud to be recognized by the White House for its commitment to improving access to cancer screenings for its employees. We firmly believe that regular cancer screenings should be accessible to everyone, including our employees and their families. To emphasize the significance of preventive healthcare, we offer financial incentives to our employees in our medical plans, which are up to $325 per year for completing their recommended preventive care, including cancer screenings. These incentives encourage our employees to take proactive steps toward their preventive care. In addition, our medical plans cover 100% of the costs for routine screenings related to breast, cervical, colorectal, and lung cancers. http://spr.ly/6042jPGSO #BidenCancerMoonshot

In honor of Asian American, Native Hawaiian and Pacific Islander (AANHPI) Heritage Month, we’re shining a light on three of our employee resource groups: “Empowering Communities of Oceania (ECO)”, “Asian Pacific Community (APAC^2)” and “South Asian Network at Genentech (SANG)". These groups, representing over 1,800 employees, support our vibrant AANHPI community at Genentech by fostering connection, advancing career development and celebrating the rich and diverse cultures within these communities. Learn more about how our employees are actively embracing our increasingly diverse workplace and world: http://spr.ly/6040jHdGr #AANHPIHeritageMonth

While innovative therapies developed over the past few decades have helped prevent blindness and maintain quality of life among those living with serious eye conditions, more options are needed to address the distinct challenges of vision loss. To do this, our researchers are focusing on early identification of at-risk patients and even individualized treatments based on eye genetics and biomarkers – with the goal of stopping vision loss before it even occurs. Join our ophthalmology research leaders Chris Brittain and Dolly Chang in S5E02 of our podcast Two Scientists Walk Into a Bar, as they dive deeper into ongoing advances in preventing vision loss: http://spr.ly/6048jGlwn

Last week, we were honored to host a visit from South San Francisco Assemblywoman, Diane Papan and South San Francisco Unified School District Superintendent, Dr. Shawnterra Moore. During their visit, they were able to attend our Gene Academy program and observe South City students in the 3rd through 5th grades build compasses and electromagnets in a fun science experiment. At our company, we believe that children are natural scientists, engineers, and problem solvers, but many students in under-resourced schools do not have access to regular science instruction. That’s why we created Gene Academy, an after-school mentoring program for students to get them excited about science. Learn more about how Gene Academy here: http://spr.ly/6048jH8qg